• CAGT Grant and Contract Proposal Submission Form

  • Please submit this form to start your proposal process. To ensure we can provide you with the best support, we kindly ask that you complete it 4 to 6 weeks before your submission deadline.

    For questions regarding BCM’s Sponsored Programs Policies and Procedures, please visit this page.

  • General Information

  • Grant Type*
  • Sponsor Deadline*
     - -
  • Budget Period
     - -
  •  - -
  • Is there a subcontract?*

  • Subcontract Information

  • Is this a limited grant submission (only one submission allowed per institution)?
  • Does this application involve multiple Principal Investigators (MPI)?

  • Additional Information

  • Purpose?*
  • Funding Instrument*
  • Cancer-related Grant?*

  • Assurances

  • Animal subjects?*
  • Human subjects?*

  • At least 1 of the following 2 questions below must be answered "Yes." This must be done for each protocol listed.

  • If a protocol is identified at the time of submission: Does the proposal provide monetary funding or in-kind support for research involving human subjects?*

  • Note: Monetary funds or in-kind support means you are linking that protocol because the proposal provides money or in-kind contributions e.g., office/lab space, equipment, devices, drugs, supplies, and other non-monetary support.

    If this proposal is awarded, you will need to amend the protocol to add the funding source before it will be funded in BRAIN.

  • Is your linked protocol a source of tissue or data for the activities on the proposal?*

  • Note: “Source of tissue or data only” means that the protocol linked is not being funded by the proposal, but rather a source for tissue or data for the covered activities on the proposal.

  • Is this a clinical trial?*
  • Will the proposed research use de-identified data?*
  • Is this an Agency-Defined Phase III Clinical Trial?*
  • Have you spoken to the CRO concerning this Clinical Trial?*
  • Do we need to involve the CRO regarding the budget (has patient enrollment, clinical milestones/deliverables)?*
  • Does the proposed research involve human specimens and/or data?*
  • Does the study enroll or collect personal data from individuals residing in any of the following countries: European Union (EU) countries, European Economic Areas (EEA), the United Kingdom or Switzerland?*
  • Recombinant DNA?*

  • Note: If you answered "yes" to recombinant or synthetic nucleic acid molecules research, the IBC protocol must be submitted for review and approval by the Institutional Biosafety Committee before work may be initiated. 

  • Lasers?*

  • If you answered "yes" to Lasers (including all laboratory equipment containing Class 3B or Class 4 lasers), a Laser protocol must be submitted to the Radiation Safety Committee for review and approval before work may be initiated.

  • X-Ray Machines?*

  • If you answered “yes” to X-ray Machines (including mammography), an X-ray protocol must be submitted to the Radiation Safety Committee for review and approval before work may be initiated.

  • Radioactive Materials?*

  • If you answered "yes" to Radioactive Materials, a Radioactive Materials protocol must be submitted to the Radiation Safety Committee for review and approval before work may be initiated.

  • Irradiators?*

  • If you answered "yes" to Irradiators, an irradiator use registration form must be submitted to the Radiation Safety Committee for review and approval before work may be initiated. All personnel must be approved for unescorted access to BCM irradiators, a process that may take up to six weeks to complete. For additional information, contact Environmental Safety at 713-798-5268.

  • Human Embryonic Stem Cells?*

  • If the proposed project involves human embryonic stem cells, list the registration number of the specific cell line(s) below from the following list: https://stemcells.nih.gov/registry/eligible-to-use-lines. Or, if a specific stem cell line cannot be referenced at this time, please indicate that one from the registry will be used.

  • Dual Use Research of Concern Materials?*

  • If you answered "yes" to Dual Use Research Concern Materials, an application must be submitted to the Institutional Use Research of Concern Committee (IDURCC) for evaluation and approval.

  • 0/8000
  • 0/1000

  • Foreign Component

    A foreign component is defined as the performance of any significant scientific element of segment of a project outside of the United States, either by the recipient or by a research employed by a foreign organization, whether or not grant funds are expended. Baylor College of Medicine uses the PHS Grants Policy definition in this determination. An affirmative answer to any of the following questions will determine whether or not there is a foreign component on this application.
  • Are any portions of this project's activities planned to be conducted with collaborations with investigators at a foreign site anticipated to result in co-authorship?*
  • Are any portions of this project's activities planned to be conducted with the use of facilities or instrumentation at a foreign site?*
  • Are any portions of this project's activities planned to be conducted with the receipt of financials for resources from a foreign entity?*
  • Are any portions of this project's activities planned to be conducted with the involvement of human subjects or animals outside the United States?*
  • Are any portions of this project's activities planned to involve extensive foreign travel by recipient project staff for the purpose of data collection, surveying, sampling, and similar activities?*
  • Could any portions of this project's activities have an impact on U.S. foreign policy through involvement in the affairs or environment of a foreign country?*

  • Budget Details

  • Browse Files
    Drag and drop files here
    Choose a file
    Cancelof
  • Should be Empty: